Suchergebnisse - "Hassaniazad, Mehdi"

PubPharm (40)

1

Evaluation of short-term adverse events of COVID-19 vaccines : An observational study

enthalten in: Medicine | 2024

von Fathi, F. | Ameri, A. | Safa, O. | +2

2

The effects of Annual SZ drug on dynamic changes in lymphocytes and cytokines of COVID-19 patients : A randomized clinical trial

enthalten in: International immunopharmacology | 2024

von Soltaninejad, E. | Mohammad Hassan, Z. | Yekaninejad, M. | +4

3

Concurrent emphysematous cystitis and emphysematous pyelonephritis in a patient with extrarenal pelvis

enthalten in: CEN case reports | 2023

von Barahimi, E. | Basham, A. | Evazi, E. | +3

4

Absence of Asymptomatic Malaria Reservoirs in an Area with a Previous History of Local Malaria Transmission : A Successful Experience in Line with the Malaria Elimination Program in Iran

enthalten in: Journal of arthropod-borne diseases | 2023

von Hosseini, Z. | Azizi, K. | Moghadami, M. | +4

5

Developing a mobile health application for wound telemonitoring : a pilot study on abdominal surgeries post-discharge care

enthalten in: BMC medical informatics and decision making | 2023

von Baniasadi, T. | Hassaniazad, M. | Rostam Niakan Kalhori, S. | +2

6

Developing a mobile health application for wound telemonitoring: a pilot study on abdominal surgeries post-discharge care

enthalten in: BMC medical informatics and decision making | 2023

von Baniasadi, T. | Hassaniazad, M. | Rostam Niakan Kalhori, S. | +2

7

Developing a mobile health application for wound telemonitoring: a pilot study on abdominal surgeries post-discharge care

enthalten in: BMC medical informatics and decision making | 2023

von Baniasadi, T. | Hassaniazad, M. | Rostam Niakan Kalhori, S. | +2

8

Characterization of SARS-CoV-2 isolated from a patient in Iran compared to SARS-CoV-2 different variants

enthalten in: Journal of biomolecular structure & dynamics | 2023

von Ahmadi, K. | Hosseinpour, M. | Rismani, E. | +5

9

Preparation and pre-clinical evaluation of flagellin-adjuvanted NOM vaccine candidate formulated with Spike protein against SARS-CoV-2 in mouse model

enthalten in: Microbial pathogenesis | 2022

von Farshidi, N. | Ghaedi, T. | Hassaniazad, M. | +7

10

Efficacy and safety of favipiravir plus interferon-beta versus lopinavir/ritonavir plus interferon-beta in moderately ill patients with COVID-19 : A randomized clinical trial

enthalten in: Journal of medical virology | 2022

von Hassaniazad, M. | Farshidi, H. | Gharibzadeh, A. | +4